VOACON: 24th and 25th May 2023 – Grand Hotel Leicester

Animalcare UK Ltd is really pleased to be supporting the first VOACON as a Platinum sponsor. This event is important, bringing together those interested in improving the treatment and management of osteoarthritis (OA) from across the veterinary sector.

This inaugural two-day Veterinary Osteoarthritis Congress brings together the foremost minds at the cutting-edge of osteoarthritis treatment and management and the companies pushing the developments in technology and treatment.

View the programme here: VOACON Programme

Osteoarthritis is a complex condition which may remain with affected animals for many years. There is no single strategy that can effectively deal with the full range of issues that arise for the animal and owner from the point of diagnosis and which may vary over time. It is only by using a range of approaches that we can fully safeguard the welfare of the animals we seek to treat. Many of these strategies are brought together for the first time in the UK and highlighted in the exciting programme at VOACON. We hope to see this event well supported and look forward to talking to delegates.

Daxocox®, the first and only weekly oral NSAID for the treatment of pain and inflammation associated with osteoarthritis in dogs, seeks to help owners with convenient and effective long-term pain control for their dog; and Danilon® Equidos Gold for horses with osteoarthritis and other painful musculo-skeletal conditions. Both these products provide the veterinary professional with tools in the armoury to assist with the long-term management of OA.

Animalcare is a sustainable and passionate organisation committed to leading in animal health through innovative and trusted products and services to support the veterinary profession. Please visit us on our stand and also join us in our presentations at VOACON where we will be highlighting the role that non-steroidal anti-inflammatory drugs (NSAIDs) can play in long term condition management for OA.

Haven’t got your ticket yet – Book Now 

 

Daxocox – Active substance: Enflicoxib UK POM-V, Legal category: POM-V, 15mg UK Vm 32742/5001, NI EU/2/21/270/001-007, 30mg UK Vm 32742/5002, NI EU/2/21/270/008-014, 45mg UK Vm 32742/5003, NI EU/2/21/270/015-021, 70mg UK Vm 32742/5004, NI EU/2/21/270/022-028, 100mg UK Vm 32742/5005, NI EU2/21/270/029-035. Daxocox is indicated for the reduction of pain associated with osteoarthritis in dogs and contains Enflicoxib.
Please refer to the SPC or package leaflet for full product information including side effects, precautions, warnings and contra-indications before use.
USE MEDICINES RESPONSIBLY.
Daxocox® is a registered trademark of Animalcare Group Plc

 

Danilon Equidos Gold – Active substance: Suxibuzone UK POM-V Vm 46037/4006. Danilon is indicated for treatment of pain and inflammation associated with musculo-skeletal conditions in the horse eg osteoarthritic conditions, bursitis, laminitis and soft tissue inflammation.
Please refer to the SPC or package leaflet for full product information including side effects, precautions, warnings and contra-indications before use.
USE MEDICINES RESPONSIBLY.
Danilon® Equidos Gold is a registered trademark